Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Peterse

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Pathology|November 11, 2008
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancerC Holm, M Kok, R Michalides, et al.
The Journal of Pathology|March 13, 1998
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situW J De Leeuw, G Berx, C B Vos, et al.
Cancer Research|October 1, 1992
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancerE Schuuring, E Verhoeven, H van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trialsA C Voogd, M Nielsen, J L Peterse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853N Bijker, J L Peterse, L Duchateau, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancerE E Deurloo, P J Tanis, K G A Gilhuijs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 1999
The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancerA C Voogd, F van der Horst, M A Crommelin, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 12, 2002
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"]E J Th Rutgers, J W R Nortier, M K Tuut, et al.
Annals of Surgical Oncology|March 1, 1997
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dyeB A Kapteijn, O E Nieweg, I Liem, et al.
British Journal of Cancer|January 1, 1997
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesisC B Vos, A M Cleton-Jansen, G Berx, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Pathology|November 11, 2008
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancerC Holm, M Kok, R Michalides, et al.
The Journal of Pathology|March 13, 1998
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situW J De Leeuw, G Berx, C B Vos, et al.
Cancer Research|October 1, 1992
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancerE Schuuring, E Verhoeven, H van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trialsA C Voogd, M Nielsen, J L Peterse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853N Bijker, J L Peterse, L Duchateau, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancerE E Deurloo, P J Tanis, K G A Gilhuijs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 1999
The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancerA C Voogd, F van der Horst, M A Crommelin, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 12, 2002
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"]E J Th Rutgers, J W R Nortier, M K Tuut, et al.
Annals of Surgical Oncology|March 1, 1997
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dyeB A Kapteijn, O E Nieweg, I Liem, et al.
British Journal of Cancer|January 1, 1997
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesisC B Vos, A M Cleton-Jansen, G Berx, et al.
Pageof 13